Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes

NCT05901259 is registered in ClinicalTrials.gov with Otto Bock Healthcare Products GmbH as lead sponsor.

NCT NCT05901259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05901259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
Lead sponsor
Otto Bock Healthcare Products GmbH
Phase
Observational
Overall status
Recruiting
Start date
February 18, 2026
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, fibromyalgia, multiple sclerosis, neurologic disorder, stroke